News & Events

Toft Group Completes Search for Vice President, Sales & Business Development for Northway Biotech, Inc. in San Francisco, CA

Executive search firm Toft Group has placed Laura King as Vice President, Sales and Business Development for Northway Biotech in San Francisco, CA.

Ms. King has over 20 years in business development within the biotech industry. She previously served as Senior Director for CMC Biologics, and Business Development Manager for Cook Pharmica. She has also worked in business development with Novozymes, Catalent Pharma Solutions and JRH Biosciences. Ms. King holds a bachelor of science in psychology/neuroscience from Northeastern University.

About Northway Biotech

Northway Biotech is a startup affiliate of Biotechpharma, a contract development and manufacturing organization (CDMO), supporting clients world-wide. Biotechpharma performs different projects at any stage, starting from cell line construction and process development up to cGMP production of biopharmaceutical products.

Toft Group Appoints Dani Gavson as Vice President

Team expansion driven by ongoing talent-gap crisis, which has accelerated demand for top healthcare executives

Toft Group Executive Search, a global life sciences and healthcare high-tech executive recruiting firm with offices in San Francisco, San Diego and Boston, today announced Dani Gavson has joined Toft Group as vice president.

“Toft Group is expanding to meet customers’ increasing calls for highly qualified, diverse executive candidates working at the intersection of biotech and high-tech,” said Robin Toft, founder, president and chief executive officer of Toft Group. “As today’s talent gap becomes a hiring crisis, the need for experienced and talented executive search professionals has grown. We are excited that Dani has joined Toft Group to help fill that need, since she has a strong track record of placing hard to hire executives.”

Ms. Gavson joins Toft Group with more than 25 years as an executive search consultant specializing in life sciences. She has worked with executive search firms both in South Africa and the United States, and owned her own San Diego-based firm. Ms. Gavson has placed exceptional and highly sought-after industry experts in all phases of the drug development life cycle – including translational research, clinical research and development, and medical affairs in many of the world’s leading companies in North America and globally. She also has many years of expertise in identifying highly skilled physicians and physician scientists for executive roles in the pharmaceutical and biotech sector.

Ms. Gavson obtained her bachelor’s degree in commerce from the University of the Witwatersrand, Johannesburg.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

Toft Group Completes Search for Chief Medical Officer and Senior Vice-President of Medical Affairs for Natera, Inc. (NASDAQ: NTRA), in San Carlos, CA

SAN DIEGO, CA, April 9, 2018– Executive search firm Toft Group has placed Paul R. Billings, M.D, Ph.D., as Chief Medical Officer and Senior Vice-President of Medical Affairs at Natera, Inc. in San Carlos, CA.

Dr. Billings is a leading authority on genomics and diagnostics in medical practice and he will help lead Natera’s efforts across reproductive health, oncology, and new emerging businesses. Natera is a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA (cfDNA).

“We are thrilled to have Dr. Billings join Natera,” said Matthew Rabinowitz, Ph.D., Natera’s CEO. “Paul’s vision and expertise in applied genetics and personalized medicine are rare in the industry, and his experience working with CMS, FDA, commercial payors, academic institutions and patient advocacy groups will help us demonstrate clinical utility and improve patient access to our products and services.”

“Paul is a highly experienced medical affairs leader, with the ability to drive growth and awareness for diagnostic tests and services. We anticipate he will add great value to the Natera team as they introduce new products and services to the market” said Robin Toft, CEO of Toft Group Executive Search.

Dr. Billings is a board-certified internist and clinical geneticist with more than 30 years of experience in genomics and molecular medicine. He is the author of nearly 200 publications on genomic medicine and has held academic and research appointments at Harvard University, UC San Francisco, Stanford University, and UC Berkeley. Prior to joining Natera, Dr. Billings was Chief Medical Officer of Life Technologies, Inc., and consulting CMO of the Genetic Sciences Division of Thermo Fisher Scientific. He previously was SVP and Senior Physician at Laboratory Corporation of America Holdings. He has served on the Scientific Advisory Board of the Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the HHS Secretary’s Advisory Committee on Genomics, Health and Society. His work formed the basis of the Genetic Information Nondiscrimination Act of 2008 (GINA).

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About Natera

Natera is a global leader in cell-free DNA testing. The mission of the company is to transform the diagnosis and management of genetic diseases. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform.

Toft Group Completes Chief Commercial Officer Search for IRRAS, Inc. (NASDAQ Stockholm: IRRAS), in San Diego, CA

Executive search firm Toft Group has placed Mr. William “Carl” Martin, Jr. as Chief Commercial Officer and a member of the executive management team at IRRAS, Inc. in La Jolla, CA.

Mr. Martin has nearly 20 years of commercial, marketing, and executive experience in the medical device field with expertise in driving aggressive revenue growth for multiple product platforms in both emerging and large companies. In this newly created role, Mr. Martin will report directly to the President and CEO of IRRAS, Kleanthis G. Xanthopoulos, Ph.D., at the San Diego site.

“We’re thrilled to welcome Will to the IRRAS team as we accelerate the commercial planning for our IRRAflow™ products,” said Dr. Xanthopoulos. “Will’s commercial and leadership experience will be invaluable to IRRAS as we build our commercial infrastructure to realize revenue growth in Europe while expanding into attractive new markets like the United States.”

Robin Toft, President and CEO of Toft Group said: “We are excited about the future for IRRAS, an impressive local company changing the practice of medicine, and congratulate Will Martin on his new role. We have every confidence that he will make an exceptional contribution to the company’s continued success.”

Mr. Martin commented, “I have dedicated much of my career to providing patients with access to innovative medical devices, and, by joining IRRAS, I am pleased to continue this work by guiding the commercial strategies for IRRAflow™. We have a tremendous opportunity to revolutionize the treatment of hemorrhagic strokes, and I look forward to working with the experienced team at IRRAS to accomplish our goals.”

Most recently, Mr. Martin served as General Manager of the Peripheral Vascular (PV) devices business for Philips Healthcare, a global healthcare technology conglomerate. In this role, Mr. Martin oversaw the growth and expansion of Philips into the PV interventional space, was responsible for defining and owning the global PV business strategy, and played a key role in the acquisition of Spectranetics for more than $2B. During his tenure, the PV segment was one of the fastest growing businesses in Philips.

Prior to Philips, Mr. Martin was Vice President of Commercial Operations and Vice President of Marketing and Business Development at AtheroMed, Inc. (acquired by Volcano, Inc). In this key leadership role, he developed the global launch strategy for the Phoenix Atherectomy System and hired and led the initial US sales force during the product’s successful initial market introduction.   He served as Vice President of Sales and Marketing at Hotspur Technologies, Inc. (acquired by Teleflex), the VP of International Sales at AccessClosure, Inc. (acquired by Cardinal Health), and held other key commercial roles at Boston Scientific Corporation, Aventis Pharmaceuticals, and Corning, Inc.

Mr. Martin was a Lieutenant in the U.S. Navy, and he received a BA from Notre Dame and an MBA from Johns Hopkins University.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. Toft Group’s targeted, accurate search process translates into exceptional return-on-investment for clients nationwide.  The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.

About IRRAS USA, Inc.

IRRAS (NASDAQ Stockholm: IRRAS), is a publicly-traded, commercial-stage medical technology company focused on designing, developing and commercializing innovative solutions for various brain pathologies, with a goal of dramatically improving patient outcomes, reducing patient-time in the intensive care unit and medical ward, and providing significant health economic benefits to hospitals and healthcare providers. The Company’s initial product focus is on intracranial fluid management solutions that utilize its proprietary platform technology, IRRAflow™, which is a CE-marked, fully integrated, closed-circuit medical device system that enables intelligent intracranial fluid management as well as accurate, real-time monitoring of intracranial pressure.

With its unique product portfolio, protected by key intellectual property patents and patent applications, IRRAS is well-positioned to improve patient outcomes and establish a leadership position in the medical device market. IRRAS maintains its headquarters in Sweden with corporate offices in Germany and San Diego, CA, USA.

Toft Group Completes Executive Search for eMolecules Inc. in La Jolla, CA

Executive search firm Toft Group has placed Ms. Jennifer Huang as Director of Client Services at eMolecules Inc. in La Jolla, CA.

Ms. Jennifer Huang has over 15 years as a technical leader across customer support and project management. She joined Illumina as Customer Success Manager and Senior Support Representative after completing her degree in Biology from UCSD. In this role, she was responsible for customer service, project management, troubleshooting and mentoring frontline team. Prior to Illumina, Ms. Huang spent a decade with Geico as an Internet Team Lead & Customer Service Coach. Here, she oversaw business operations and process improvement, training and performance management along with product strategy and customer excellence. She holds a BS in Biology from the University of California, San Diego.

About eMolecules Inc.

eMolecules wants to reduce the time taken to discover the therapies that improve health and well-being worldwide, by enabling drug discovery scientists to explore uncharted research space, elevate their supply chain intelligence, empower their decision making, enhance their supply chain workflows and economize their research spend. Their business intelligence data and integrated ecommerce software for screening compound, chemical building blocks and primary antibody supply chains, combined with acquisition, aggregation and analytical services, greatly empower drug discovery researchers working in the pharmaceutical, biotechnology, academia, CRO and agrochemical industries. A privately-owned company, eMolecules was founded in 2005 at its San Diego/La Jolla headquarters and has offices in Boston and London.

Toft Group Appoints Ronald Giannotti as Chief Operating Officer

Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, announced Ronald Giannotti has been appointed as Toft Group’s chief operating officer. Mr. Giannotti has more than 35 years of healthcare sales, marketing and executive leadership experience, with a particular focus on medical diagnostic and therapeutic devices. He will oversee Toft Group’s corporate development, client care, marketing and sales teams and lead the San Francisco branch of Toft Group.

“Demand for top talent, particularly qualified diverse candidates, is at an all-time high as healthcare companies recognize a talent gap has emerged, driven by waves of baby-boomer retirements,” said Robin Toft, founder, president and chief executive officer of Toft Group. “Ron is a proven leader with an extensive track record of building successful healthcare companies. His strategic leadership and deep network will be instrumental as we help clients navigate through this talent crisis and continue to find the best job candidates quickly.”

Prior to joining Toft Group, Mr. Giannotti was the president and chief executive officer of Trinity Orthopedics, a company advancing innovative implants and instrumentation for minimally invasive spine surgery. Previous to this role, he founded KFx Medical, LLC, which focused on the design and manufacture of soft tissue fixation implants for orthopedic sports surgeons. Prior to this position he was the vice president of global marketing and sales for Guidant Corporation (now Boston Scientific), overseeing the cardiac and vascular surgery division, and prior to that role he was vice president of marketing and sales at EndoVascular Technologies, Inc. until its acquisition by Guidant Corporation. He was also the vice president of global marketing in the Edwards Critical Care division at Baxter International Inc., and national sales manager in the Edwards Heart Valve Division at Baxter International Inc.

“Toft Group’s ability to find top-notch talent for executive positions in healthcare, including highly qualified diverse candidates, is unparalleled,” said Mr. Giannotti. “I look forward to applying my experience in the medical device and health-tech industry to build upon the firm’s established success and further grow the company.”

Mr. Giannotti holds a bachelor’s degree in finance and entrepreneurship from the University of Southern California.

About Toft Group Executive Search

Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies at the intersection of biotech and high tech. Toft Group’s targeted, accurate searches translate into exceptional return-on-investment for clients nationwide, and the team’s extensive networks enable the presentation of more highly qualified and diverse candidates than clients would otherwise see. The firm’s extensive track record has shown its ability to quickly fill highly specialized leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Diego, San Francisco and Boston.

Toft Group Completes Executive Search for ImpediMed (ASX: IPD) in Carlsbad, CA

Executive search firm Toft Group has placed Mr. Mark Rabe as Vice President, Sales and Revenue at ImpediMed Limited (ASX: IPD) in Carlsbad, CA. Mr. Rabe was previously Senior Vice President of Advanced Resurfacing Technologies. He also served as Vice President of Sales-North America with Esaote, a medical equipment manufacturer, where he provided strategic direction to US and Canada sales teams targeting the Ultrasound and MRI markets.  Mr. Rabe was the VP of Sales West Region for AccuVein Inc. Earlier in his career, Mr. Rabe was the National Sales Director for Ultrasound at Philips Healthcare and a National Sales Manager at Siemens Healthcare.  Mr. Rabe holds a BS in Business Administration from Midland University School of Business.

About ImpediMed

Founded and headquartered in Brisbane, Australia, with offices in Carlsbad, CA, ImpediMed is the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of tissue composition and fluid status. ImpediMed produces a family of FDA cleared and CE Marked medical devices, including SOZO® for multiple indications including heart failure and lymphoedema, sold in select markets globally.

 

Toft Group Completes Executive Search for Therapeutics, Inc. in San Diego, CA

Executive search firm Toft Group has placed Mr. Eric Feffer as Director of Clincial Operations at Therapeutics, Inc. in San Diego, CA. Mr. Feffer was previously with Agility Clinical as Director of Project Management, where he led operations, clinical trial management and project oversight. He has also worked with Synteract, Clinimetrics Research Associates/Omnicare Clinical Research, and Quintiles, Inc. in a number of project management roles. He holds an MBA from the University of Southern California and a BS in Biopsychology from the University of California, Santa Barbara.

About Therapeutics, Inc.

Therapeutics, Inc. designs, creates, and executes development programs for FDA registration of topical, oral and injectable dermatology drugs, biologics and devices. In addition to designing and managing Phase 1-4 dermatology studies, they maximize clients’ commercial success by supporting management of competitive technologies, regulatory strategy and compliance, market dynamics, competitive intelligence, reimbursement, product life cycle, and more.

Toft Group Completes Executive Search for OPKO Health, Inc. (NASDAQ: OPK) in Miami, FL

Executive search firm Toft Group has placed Ms. Jennifer LaVecchia as Director of Project Management at OPKO Health, Inc. in Miami, FL. Jennifer is a PMP with 15+ years of industry experience in product and program management, sales and marketing. She has worked in project management with Noven Pharmaceuticals, LifeExtension, and Goodwin Biotechnology.  Earlier in her industry career, she held sales and marketing roles with LevTech and Monsanto.  She holds an MA in Marketing from Webster University.

About OPKO Health, Inc.

OPKO Health is a diversified healthcare company that seeks to establish industry leading positions in large, rapidly growing markets. Their diagnostics business includes Bio-Reference Laboratories, the nation’s third-largest clinical laboratory with a core genetic testing business and a 400-person sales and marketing team to drive growth and leverage new products, including the 4Kscore® prostate cancer test and the Claros® 1 in-office immunoassay platform. Their pharmaceutical business features RAYALDEE, an FDA-approved treatment for secondary hyperparathyroidism  in stage 3 and 4 chronic kidney disease patients with vitamin D insufficiency. OPKO also has production and distribution assets worldwide, multiple strategic investments and an active business development strategy.

Toft Group Completes Executive Search for Cell Medica, Inc. in Houston, TX.

Executive search firm Toft Group has placed Mr. Kevin Boyle, Sr. as Chief Financial Officer at Cell Medica, Inc., in Houston, TX. With over 20 years of financial and capital markets experience, Kevin joins the senior executive team as the company prepares for ground-breaking clinical trials to investigate cancer treatments utilizing Cell Medica’s innovative chimeric antibody receptor (CAR) and engineered T cell receptor (TCR) cell therapies.

Kevin has held senior finance roles at both NASDAQ-listed and private equity backed companies. He is an accomplished capital markets professional with strong banking relationships cultivated by raising over $2.0 billion in equity and debt capital. Kevin received a law degree from the University of Pennsylvania and a BS in Industrial Management & Economics from Carnegie Mellon University.

About Cell Medica

Cell Medica is committed to transforming patients’ lives through developing the significant therapeutic potential of cellular immunotherapy for the treatment of cancer. In collaboration with our strategic partners, Cell Medica is developing a range of products using three proprietary technology platforms including activated T cells, chimeric antigen receptors (CARs) and engineered T cell receptors (TCRs). Our lead product is CMD-003 is being tested in an international Phase II trial for the treatment of cancers associated with the oncogenic Epstein Barr virus. We are working with the Baylor College of Medicine and the University of North Carolina to develop next generation CAR- modified NKT cells including an off-the-shelf product. In the field of engineered TCRs, we are collaborating with University College London to develop the Dominant TCR technology platform.

Cell Medica is headquartered in London with subsidiaries in Zurich and Houston.

How to Navigate #MeToo at Work

Toft Group is proud to present this guest post by our friend and colleague Patti Perez of Emtrain.  Patti is an expert in transforming workplace culture, and she has been leading a series of live events partnered with Toft Group on the subject of harrassment in the workplace.

Robin Toft, Patti Perez (Emtrain), and Linda Sierra (Toft Group) at the San Diego presentation to HR leaders

How to Navigate #MeToo at Work
By Patti Perez, Emtrain

I know, I know. It’s the last thing we want to talk about—especially in the workplace. Actually, the truth of the matter is, this sticky subject has opened up a floodgate of productive discussion in the corporate arena and I really do think we’re just getting started!

My combined experience as an attorney, human resource (HR) executive and entrepreneur has equipped me with the expertise to tackle topics such as this that largely impact our communication and decision making in the workplace.

For International Women’s Day, I partnered with Toft Group to give a presentation to San Diego’s HR leaders where we discussed tangible ways to make sense of the #MeToo movement in the workplace. These three key takeaways from our discussion highlight how companies can avoid enabling a culture of complicity and inaction:

  1. Complying with the law is not enough

Sure, compliance is important. I am a lawyer after all. But if your company’s number one concern is simply following the law, you’ve got a bigger problem on your hands than you may realize. By over-focusing on compliance, employees may begin to think, “Oh great, all you want to do is prevent unlawful harassment from occurring… not bullying, disrespectful behavior or sexually charged comments.” This clearly won’t lend itself to a very welcoming or productive environment.

  1. Address the problem early, and head on

The #MeToo movement was brought on by a group of women who were fed up with the chronic inaction that surrounds sexual harassment. Actively investigating these incidents as soon as they occur or are reported will prevent the incidents from escalating in severity and also protect both the employee and the company. Plus, honestly, it’s just the right thing to do!

  1. Enable change and empower those around you

How can you use this movement to make a positive impact on your company? A good place to start is by making sure your employees are comfortable with reporting instances of sexual harassment. Did you know that in a recent survey of in-house attorneys, their response to the question of “Are your employees comfortable reporting misconduct?” was a measly 30% — meaning that a staggering 70% are NOT comfortable reporting. Let’s change that number by continuing this crucial dialogue and providing the resources necessary to take action. It is also vital to empower women and other underrepresented employees to pursue board positions and executive leadership roles in order to allow a different perspective to surface when it comes to sexual harassment in the workplace.

Hopefully these insights will help you feel more comfortable navigating #MeToo in your workplace.

Patti Perez serves as VP of Workplace Strategy for Emtrain. Learn more about Patti Perez and her work with Emtrain.

Toft Group Completes Executive Search for LabCorp, Inc. (NYSE: LH) in Atlanta, GA

Executive search firm Toft Group has placed Mr. Gregory Ballish as Vice President and General Manager at LabCorp, Inc., in Atlanta, GA.  Gregory was most recently Vice President of Commercial Operations for the Americas at Terumo BCT in Denver. Gregory is a senior executive with extensive experience in diagnostics, pharmaceutical, transfusion medicine and medical distribution markets.  He has held leadership roles within sales and marketing for companies including Abbott Labs, DuPont, Johnson & Johnson, Meridian Bioscience, and the American Red Cross.  Gregory holds an MBA from Arizona State University and a BS in Finance from Miami University.

About LabCorp

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.

Toft Group Completes Executive Search for Asuragen in Austin, TX


Toft Group Executive Search has placed Dr. Zhen Mahoney as Head of Business Development, Partnered and Companion Diagnostics with Asuragen in Austin, Texas.  Dr. Mahoney’s previous roles include Director of Sales for Fluidigm Corporation, Director of Business Development for Epic Sciences in San Diego, and Senior Pharmaceutical Business Development Lead for Thermo Fisher Scientific. Dr. Mahoney holds a Ph.D. in biology and biomedical sciences from the Washington University School of Medicine, and a BS in biochemistry and molecular biology from Peking University

 About Asuragen

Asuragen is a molecular diagnostic company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests.

Toft Group Completes Executive Search for Greenwich Biosciences in Carlsbad, CA

Executive search firm Toft Group has placed Ms. Catherine Colletti as Vice President of Sales at Greenwich Biosciences in Carlsbad, CA.  Ms. Colletti’s previous roles include Senior National Director, Cystic Fibrosis for Allergan, and Director of Sales for Aptalis Pharma. Earlier in her career Ms. Colletti held sales management roles with Quintiles, Inc. and Bristol-Myers Squibb.  She holds a Bachelor of Science in Nursing from San Diego State University.

About Greenwich Biosciences

Greenwich Biosciences is committed to improving the lives of patients by developing and commercializing cannabinoid pharmaceuticals for rare and catastrophic diseases with limited or no FDA-approved treatments. Greenwich, along with its parent company GW Pharmaceuticals plc, is currently advancing an orphan drug development program in certain childhood-onset epilepsy syndromes with its investigational drug, Epidiolex® (cannabidiol), for which a New Drug Application is currently under priority review by the U.S. Food and Drug Administration.

Beyond Compensation: How to Keep Your Best Employees

Toft Group has had an exciting start to the new year, as two impressive people have joined our talented team: Michele Mantynen as Director of Marketing Communications and Sarah Cueto as Executive Search Consultant. These stellar additions to Toft Group will move us forward in placing highly specialized leadership and technical roles in companies at the intersection of biotech and high tech.

At Toft Group, we know –  from daily experience speaking with impressive executive level candidates –  that once you have gone to the effort to identify, hire and train the perfect candidate, you want to make certain they will stay with you while you reach your goals. We have identified a number of methods to guarantee happy, engaged employees in the article “Beyond Compensation: How to Keep Your Best Employees.”
If you are ready to start a search for a new position or expand your organization, please contact our award-winning team.
Sincerely,

Robin Toft, President & CEO
Toft Group

Access the full Newsletter here

Beyond Compensation: How to Keep Your Best Employees

You’ve gone to the effort and expense to hire top performers for your company– how do you make sure they will stay with you? According to The Wall Street Journal, a high employee turnover rate can lead to costs of up to two times an employee’s salary to find and train a replacement. High turnover rates can also lower a company’s knowledge base and decrease performance and morale among the employees who remain.

How do you make sure your top performers stay? Offering attractive compensation and benefits is always a good start, but there are many other strategies for keeping your valuable employees with you.
  • Make sure your match is a strong one from the start.Hiring the right people is the single best way to reduce employee turnover. “Using an expert search firm can give you the ability to identify exactly the right candidates. Not only will these potential employees have the skills you require, they will also fit well with your company culture,” says Mark Soufleris, Senior Vice President of Toft Group. “The stronger the match, the more likely the employee will remain with your company.”
  • Effectively communicate your mission. Understanding and feeling connected to the organization’s goals keeps employees mentally and emotionally tied to your company.
  • Ensure psychological safety. Google conducted a study on team performance and the conclusion was that the highest-performing teams have one thing in common: psychological safety, the belief that you won’t be punished for making a mistake. According to The Harvard Business Review, studies show that psychological safety allows for risk-taking, speaking your mind and creativity. Creating a sense of psychological safety within your company can lead to higher levels of engagement, increased motivation to tackle difficult problems, stronger performance, and overall better job satisfaction.
  • Check in with your current employees. In addition to conducting exit interviews to learn why employees leave, consider asking long-term employees why they stay. Ask them: why did you come to work here, why have you stayed, what do you think of management, what would you improve? Use the answers to strengthen employee-retention strategies.
  • Recognize accomplishments. Feeling appreciated is crucial for most satisfied employees. You can do this in the moment with a thank-you email in which you copy the employee’s supervisor, or more formally with public recognition and appreciation in department or all-company meetings. The simple act of letting employees know you’ve noticed, understood and appreciated their work might be the most effective way to ensure they will be with you all the way to your goals.
Toft Group works with clients to source talent and develop a growth culture that fosters innovation. For more information, or to start your next search, contact us